Search for: "Roxane Laboratories, Inc." Results 21 - 40 of 55
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
19 Nov 2012, 4:00 am
Before issuing its decision, FDA received and considered public comment from Roxane Laboratories ("Roxane"), who had an Abbreviated New Drug Application ("ANDA") referencing Xyrem accepted for review in late 2010. [read post]
8 Jul 2012, 9:13 pm by Patent Docs
• Defendants: Roxane Laboratories, Inc.; Boehringer Ingelheim Roxane, Inc. [read post]
21 Jun 2012, 6:52 pm by FDABlog HPM
  Shortly before FDA received Lannett’s NDA submission, the Agency, on January 25, 2010, approved a supplement to Roxane Laboratories, Inc. [read post]
6 Nov 2011, 10:57 pm by FDABlog HPM
District Court for the District of Wyoming granting FDA’s Motion to Dismiss a lawsuit brought by Cody Laboratories, Inc. and Lannett Co., Inc. [read post]
25 Oct 2011, 3:26 am by Ben Vernia
The investigation determined that the pharmaceutical manufacturers Abbott Laboratories, Dey Inc. and Roxane Laboratories reported falsely inflated drug prices relied upon by the Medicare and Medicaid programs to determine reimbursements to pharmacies. [read post]
16 Sep 2011, 11:02 am by eithurburn@getnicklaw.com
  The state has already settled cases with Astra Zeneca, Abbott Laboratories, GlaxoSmithKline, Amgen Inc., Baxter Healthcare Corp., Boehringer Ingelhelm Roxane, and Dey Pharmaceutical and has prevailed at trial against Johnson & Johnson and Bristol-Meyers Squibb. [read post]
21 Dec 2010, 10:08 am by Phillips & Cohen
Braun Medical Inc. and Roxane Laboratories Inc.The difference between the inflated amount the government paid and the actual price paid by health care providers for a drug is referred to as the “spread. [read post]
20 Dec 2010, 2:34 pm by Phillips & Cohen
December has been a significant month in terms of False Claims Act recoveries from pharmaceutical companies.Three drug makers - Abbott Laboratories Inc., Roxane Laboratories Inc. and B. [read post]
13 Dec 2010, 4:55 pm by FDABlog HPM
District Court for the District of Columbia’s April 2, 2010 order denying motions for preliminary injunction filed by Roxane Laboratories, Inc. [read post]
13 Dec 2010, 1:51 pm by fraudfighters
Braun Medical Inc., and Roxane Laboratories Inc. to resolve lawsuits filed against the companies asserting that they violated the False Claims Act by causing false claims to be submitted to federal healthcare programs such as Medicare and Medicaid. [read post]
7 Dec 2010, 2:43 am by Ben Vernia
As for Roxane: Roxane is paying $280 million to resolve claims against it and related entities (Roxane Laboratories Inc., Boehringer Ingelheim Corp. and Boehringer Ingelheim Pharmaceuticals Inc.). [read post]
17 Nov 2010, 6:33 pm by FDABlog HPM
Karst –       In a November 16th decision that might not mark the end to the dispute between Cody Laboratories, Inc. and Lannett Co., Inc. [read post]
5 Oct 2010, 2:58 pm by FDABlog HPM
District Court for the District of Columbia’s April 2, 2010 order denying motions for preliminary injunction filed by Roxane Laboratories, Inc. and Apotex. [read post]